A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome

Completed · Phase 2 · Has a placebo group

Conditions studied: Cystitis, Interstitial, Painful Bladder Syndrome

In brief

This is a safety and efficacy study of LiRIS® in females with interstitial cystitis/bladder pain syndrome.

Key facts

Study ID
NCT02411110
Run by
Allergan
People needed
131
Starts
2015-05-21
Expected to finish
2017-01-09
Last updated by the study team
2018-01-04

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.